Enjoy complimentary customisation on priority with our Enterprise License!
The pruritus drugs market share is expected to increase by USD 6.87 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 8.06%.
This pruritus drugs market research report will help companies evaluate their business approaches. Furthermore, this report extensively covers pruritus drugs market segmentation by application (hematologic pruritus, oncological pruritus, renal pruritus, endocrine pruritus, and cholestatic pruritus) and geography (North America, Europe, Asia, and Rest of World (ROW)). The pruritus drugs market report also offers information on several market vendors, including AbbVie Inc., Almirall SA, Astellas Pharma Inc., Bristol-Myers Squibb Co., Cara Therapeutics Inc., Eisai Co. Ltd., Eli Lilly and Co., Glenmark Pharmaceuticals Ltd., Ipca Laboratories Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Roivant Sciences Ltd., Sanofi SA, Sun Pharmaceutical Industries Ltd., Cipla Ltd., GlaxoSmithKline Plc, and Lupin Ltd. among others.
Download the Free Report Sample to Unlock the Pruritus Drugs Market Size for the Forecast Period and Other Important Statistics
The growing preference for immunotherapy is notably driving the pruritus drugs market growth, although factors such as availability of alternative therapies may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the pruritus drugs industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Pruritus Drugs Market Driver
One of the key factors driving the global pruritus drugs market growth is the growing preference for immunotherapy. Pruritus is a common side effect associated with immunotherapy in patients with cancer, with regions such as the skin and hair being at a high risk of itching. The use of immunotherapy is known to release toxins from the cancerous cells, which triggers an immune response and causes pruritus. For instance, treatment using YERVOY, a cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) inhibitor, is known to cause pruritus in approximately 25%-35% of all patients, and PD-1 inhibitors such as KEYTRUDA and OPDIVO are known to cause pruritus in approximately 13%-20% of all patients. When used in combination, OPDIVO and YERVOY are known to cause pruritus in approximately 17%- 65% of all cases. Thus, the rising use of immunotherapy is expected to increase the cases of pruritus, which will drive the growth of the market during the forecast period
Key Pruritus Drugs Market Trend
One of the key global pruritus drugs market trends is the emergence of novel treatment options. Despite the clinical urgency for the need to develop efficacious drugs that can target the cause, the itching has received relatively less attention from research, and its etiology has remained poorly understood until the emergence of TRP channels and their association with itching. Growth in pruritus research in recent years has attracted established vendors to conduct studies on biologics for the treatment of pruritus. For instance, Glenmark Pharmaceuticals Ltd. is conducting Phase II clinical studies for the development of GBR 830, a monoclonal antibody that is an OX40 antagonist, for the treatment of atopic dermatitis. The drug is expected to receive marketing approval and launch during the second half of the forecast period. Such advances in the study of novel treatment options are expected to drive the growth of the market in the coming years.
Key Pruritus Drugs Market Challenge
One of the key challenges to the global pruritus drugs market growth is the availability of alternative therapies. While there are multiple drugs approved for the treatment of pruritus, the preventive nature of pruritus caused by hematological diseases is a threat to the market. For instance, iron supplements such as ferrous sulfate can be used to overcome iron deficiencies and reverse the damage. This is resulting in a reduction in demand for therapeutics for the treatment of pruritus. The availability of various alternative therapies such as phototherapy and psychosomatic therapy is also a challenge for the growth of the market. Phototherapy is a highly effective and safe treatment option, with ultraviolet-based phototherapy being the most advanced type. In addition, various home remedies and lifestyle changes, such as staying hydrated and avoiding contact with allergens in case of pruritus caused by allergies, can also reduce the risk of patients developing pruritus. Such factors are projected to negatively impact the market growth in the coming years.
This pruritus drugs market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global pruritus drugs market as a part of the pharmaceutical market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the pruritus drugs market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the pruritus drugs market encompasses successful business strategies deployed by the key vendors. The pruritus drugs market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The pruritus drugs market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the pruritus drugs market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
46% of the market's growth will originate from North America during the forecast period. The US is the key market for pruritus drugs in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).
The strong prevalence of various indications associated with pruritus in countries such as the US will facilitate the pruritus drugs market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The outbreak of COVID-19 adversely affected all the countries in North America, especially the US. A rise in the number of COVID-19 cases in the first quarter of 2020 and early 2021 led to partial lockdowns in several countries, including Canada and Mexico. Hence, the sales of pruritus drugs declined slightly through offline medical stores. However, the pandemic also led to an increase in the use of e-commerce channels, which, in turn, led to a rise in the demand for pruritus drugs through online channels. Thus, the pruritus drugs market in North America witnessed a mixed impact in Q1 2020 and Q1 2021 to some extent. Like many other pharmaceutical products, pruritus drugs were made available to the public through both online and offline channels. Thus, the market in focus will register an accelerating growth momentum during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The pruritus drugs market share growth by the hematologic pruritus segment will be significant during the forecast period. The growth is attributed to campaigns, such as The Iron Deficiency Day conducted by Vifor Pharma Management Ltd., for increasing awareness about the severity of the iron deficiency and the use of drugs to treat pruritis.
This report provides an accurate prediction of the contribution of all the segments to the growth of the pruritus drugs market size and actionable market insights on post COVID-19 impact on each segment.
Pruritus Therapeutic market - The market share is expected to increase by USD 4.01 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 5.64%.
Pruritus Drugs Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.06% |
Market growth 2022-2026 |
$ 6.87 billion |
Market structure |
Fragmented |
YoY growth (%) |
7.3 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 46% |
Key consumer countries |
US, UK, Germany, France, and China |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
AbbVie Inc., Almirall SA, Astellas Pharma Inc., Bristol-Myers Squibb Co., Cara Therapeutics Inc., Eisai Co. Ltd., Eli Lilly and Co., Glenmark Pharmaceuticals Ltd., Ipca Laboratories Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Roivant Sciences Ltd., Sanofi SA, Sun Pharmaceutical Industries Ltd., Cipla Ltd., GlaxoSmithKline Plc, and Lupin Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Application
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.